scispace - formally typeset
L

Long Chen

Researcher at Beijing University of Chemical Technology

Publications -  28
Citations -  377

Long Chen is an academic researcher from Beijing University of Chemical Technology. The author has contributed to research in topics: Peptide & Medicine. The author has an hindex of 10, co-authored 18 publications receiving 237 citations.

Papers
More filters
Journal ArticleDOI

Role of peptide self-assembly in antimicrobial peptides.

TL;DR: The influences of peptide self‐assembly on the activity and mode of action, and some specific features it introduces to the AMPs, such as particular responsiveness, improved cell selectivity and stability and sustained release are discussed.
Journal ArticleDOI

A direct determination of AFBs in vinegar by aptamer-based surface plasmon resonance biosensor.

TL;DR: The developed SPR assay is a simple, fast and sensitive approach for the detection of residual AFBs in agricultural products and foodstuffs like vinegar, and shows high specificity towards AFB1 and AFB2, but hardly bound to other toxins with similar structures.
Journal ArticleDOI

Amyloid-Forming Segment Induces Aggregation of FUS-LC Domain from Phase Separation Modulated by Site-Specific Phosphorylation

TL;DR: The RNA-binding protein fused in sarcoma (FUS) forms physiological granules and pathological fibrils, which facilitate RNA functions and cause neurodegenerative diseases, respectively, and Solid-state NMR spectroscopy and computational modeling implied that site-specific phosphorylation at Ser61 plays key roles in FUS assembly by disrupting both intra- and intermolecular interactions that maintain the amyloid core structure.
Journal ArticleDOI

Self-assembly nanostructure controlled sustained release, activity and stability of peptide drugs.

TL;DR: The self-assembly approach demonstrated in this study can be applied to a variety of therapeutic peptide drugs to improve their stability and therapeutic activity for the development of carrier-free drug delivery system.
Journal ArticleDOI

A novel antimicrobial peptide against dental-caries-associated bacteria.

TL;DR: ZXR-2 showed broad-spectrum activity against a variety of Gram-positive and Gram-negative oral bacteria, particularly the caries-related taxa Streptococcus mutans, and represents a potential therapeutic for the prevention and treatment of dental caries.